Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesLiabilities and Shareholders EquityNon-Current AssetsNon-Current Deffered RevenueOperating LeasesOther Non-Current AssetsPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Receivables - OtherRetained EarningsShareholder's EquityTotal Current LiabilitiesTotal LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Avidity Biosciences (RNA) Prepaid Assets: 2019-2025

Historic Prepaid Assets for Avidity Biosciences (RNA) over the last 6 years, with Sep 2025 value amounting to $90.2 million.

  • Avidity Biosciences' Prepaid Assets rose 171.03% to $90.2 million in Q3 2025 from the same period last year, while for Sep 2025 it was $90.2 million, marking a year-over-year increase of 171.03%. This contributed to the annual value of $40.8 million for FY2024, which is 155.66% up from last year.
  • Per Avidity Biosciences' latest filing, its Prepaid Assets stood at $90.2 million for Q3 2025, which was up 33.77% from $67.4 million recorded in Q2 2025.
  • Over the past 5 years, Avidity Biosciences' Prepaid Assets peaked at $90.2 million during Q3 2025, and registered a low of $4.0 million during Q1 2021.
  • In the last 3 years, Avidity Biosciences' Prepaid Assets had a median value of $29.8 million in 2024 and averaged $35.7 million.
  • Per our database at Business Quant, Avidity Biosciences' Prepaid Assets surged by 472.65% in 2021 and then declined by 23.16% in 2022.
  • Over the past 5 years, Avidity Biosciences' Prepaid Assets (Quarterly) stood at $5.6 million in 2021, then spiked by 118.20% to $12.2 million in 2022, then soared by 30.63% to $16.0 million in 2023, then skyrocketed by 155.66% to $40.8 million in 2024, then spiked by 171.03% to $90.2 million in 2025.
  • Its Prepaid Assets was $90.2 million in Q3 2025, compared to $67.4 million in Q2 2025 and $55.1 million in Q1 2025.